Molecular basis of angiopathy in diabetes mellitus.
Silvestre
Jean-Sébastien
JS
Lévy
Bernard I
BI
D043925:Angiogenesis Inducing Agents / Q000378:metabolism*; D000818:Animals; D000077214:Becaplermin; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000503:physiopathology; D017127:Glycation End Products, Advanced / Q000096:biosynthesis; D006614:Hindlimb / Q000098:blood supply; D006801:Humans; D007511:Ischemia / Q000503:physiopathology*; D051379:Mice; D018919:Neovascularization, Physiologic; D010982:Platelet-Derived Growth Factor / Q000502:physiology*; D011493:Protein Kinase C / Q000502:physiology*; D020574:Proto-Oncogene Proteins c-sis
D043925:Angiogenesis Inducing Agents; D017127:Glycation End Products, Advanced; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin; D011493:Protein Kinase C